HEWA / HealthWarehouse.com, Inc. - SEC Filings, Annual Report, Proxy Statement

HealthWarehouse.com, Inc.
US ˙ OTCPK

Basic Stats
CIK 754813
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to HealthWarehouse.com, Inc.
SEC Filings (Chronological Order)
This page provides a complete, chronological list of SEC Filings, excluding ownership filings which we provide elsewhere.
April 18, 2017 EX-24.1

POWER OF ATTORNEY

POWER OF ATTORNEY Know by all these presents, that the undersigned, Joseph Peters, hereby makes, constitutes and appoints each of Mark F.

April 14, 2017 15-12G

HealthWarehouse.com FORM 15

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 000-13117 HEALTHWAREHOUSE.COM, INC. (Exact name of registrant as specified

April 13, 2017 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) of the SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 11, 2017 HEALTHWAREHOUSE.COM, INC. (Exact name of registrant as specified in charter) Delaware 000-13117 22-2413505 (State or other jurisdiction of incorporation) (Commission File Number) (IR

April 10, 2017 EX-10.3

HEALTHWAREHOUSE.COM, INC. SHARES OF COMMON STOCK SUBSCRIPTION AGREEMENT

Exhibit 10.3 HEALTHWAREHOUSE.COM, INC. SHARES OF COMMON STOCK SUBSCRIPTION AGREEMENT This Agreement, dated as of , 2017, is made and entered into between HealthWarehouse.com, Inc., a Delaware corporation (the "Company"), and (the "Investor"). This Agreement sets forth the terms under which the Investor will purchase from the Company shares of the Company's $0.001 par value per share Common Stock (

April 10, 2017 EX-10.1

COGNOVIT PROMISSORY NOTE

EXHIBIT 10.1 COGNOVIT PROMISSORY NOTE $1,000,000.00 April 7, 2017 1. Promise To Pay. The undersigned HEALTHWAREHOUSE.COM, INC., a Delaware corporation, HWAREH.COM, INC., a Delaware corporation, and HOCKS.COM, INC., an Ohio corporation, all with an address at 7107 Industrial Road, Florence, Kentucky 41042, jointly and severally (collectively the "Borrowers" or individually, a "Borrower"), for value

April 10, 2017 EX-10.2

SECURITY AGREEMENT

EXHIBIT 10.2 SECURITY AGREEMENT This Commercial Security Agreement ("Agreement") is made as of the 7th day of April, 2017, by HEALTHWAREHOUSE.COM, INC., a Delaware corporation, HWAREH.COM, INC., a Delaware corporation, and HOCKS.COM, INC., an Ohio corporation, all with an address at 7107 Industrial Road, Florence, Kentucky 41042 (each a "Grantor") in favor of KAPOK VENTURES LIMITED, a British Colu

April 10, 2017 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) of the SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 7, 2017 HEALTHWAREHOUSE.COM, INC. (Exact name of registrant as specified in charter) Delaware 000-13117 22-2413505 (State or other jurisdiction of incorporation) (Commission File Number) (IRS

April 4, 2017 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Financial Statements and Exhibits

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) of the SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 30, 2017 HEALTHWAREHOUSE.COM, INC. (Exact name of registrant as specified in charter) Delaware 000-13117 22-2413505 (State or other jurisdiction of incorporation) (Commission File Number) (IR

April 4, 2017 EX-10.1

SIXTH AMENDMENT TO AMENDED AND RESTATED PROMISSORY NOTE

Exhibit 10.1 SIXTH AMENDMENT TO AMENDED AND RESTATED PROMISSORY NOTE THIS SIXTH AMENDMENT TO AMENDED AND RESTATED PROMISSORY NOTE (this " Amendment") is dated March 30, 2017, by and between HEALTHWAREHOUSE.COM, INC., a Delaware corporation, HWAREH.COM, INC., a Delaware corporation, and HOCKS.COM, INC., an Ohio corporation, jointly and severally (collectively, " Borrower"), and MELROSE CAPITAL ADVI

March 21, 2017 EX-10.37

Settlement Agreement dated March 15, 2017 between the Company and Lalit Dhadphale pursuant to the Employment Agreement by and between the Company and Dhadphale. *

EX-10.37 2 exhibit1037.htm EXHIBIT1037 Exhibit 10.37 SETTLEMENT AGREEMENT AND FULL AND FINAL RELEASE OF CLAIMS This Settlement Agreement and Full and Final Release of Claims ("Agreement") is effective this 15th day of March, 2017, by and between Plaintiff, Lalit Dhadphale ("Plaintiff"), and Defendant, HealthWarehouse.com, Inc., as well as its insurers, shareholders, board members, and agents ("Def

March 21, 2017 EX-21.1

Subsidiaries of the Registrant *

EX-21.1 3 exhibit211.htm EXHIBIT211 Exhibit 21.1 Subsidiaries of the Registrant Subsidiary Jurisdiction Ownership Hwareh.com, Inc. Delaware 100% owned by HealthWarehouse.com, Inc. Hocks.com, Inc. Ohio 100% owned by HealthWarehouse.com, Inc. Ion Networks Holding N.V. Belgium 799 shares are owned by HealthWarehouse.com, Inc. One share is owned by Stephen Gray, the Company's former CEO. Ion Networks,

March 21, 2017 10-K

HEWA / HealthWarehouse.com, Inc. MAINBODY (Annual Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark one) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 0-13117 HEALTHWAREHOUSE.COM, INC. (Exact name of registrant a

March 13, 2017 8-K

HealthWarehouse.com MAINBODY (Current Report/Significant Event)

mainbody.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C., 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 13, 2017 HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdiction (Commission File Num

March 13, 2017 EX-99.1

HealthWarehouse.com Reports 4Q and Full Year 2016 Results Online and mail-order pharmacy year-over-year net sales grow 48% and exceed $10M

EX-99.1 2 exhibit991.htm EXHIBIT991 Exhibit 99.1 FOR IMMEDIATE RELEASE March 13, 2017 HealthWarehouse.com Reports 4Q and Full Year 2016 Results Online and mail-order pharmacy year-over-year net sales grow 48% and exceed $10M CINCINNATI- – (BUSINESS WIRE) - -HealthWarehouse.com, Inc. (OTCQB: HEWA) announced today that its net sales for 2016 increased 48% to $10.4 million compared to $7.0 million in

March 3, 2017 EX-10.1

FIFTH AMENDMENT TO AMENDED AND RESTATED PROMISSORY NOTE

Exhibit 10.1 FIFTH AMENDMENT TO AMENDED AND RESTATED PROMISSORY NOTE THIS FIFTH AMENDMENT TO AMENDED AND RESTATED PROMISSORY NOTE (this " Amendment") is dated February 28, 2017, by and between HEALTHWAREHOUSE.COM, INC., a Delaware corporation, HWAREH.COM, INC., a Delaware corporation, and HOCKS.COM, INC., an Ohio corporation, jointly and severally (collectively, " Borrower"), and MELROSE CAPITAL A

March 3, 2017 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) of the SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 28, 2017 HEALTHWAREHOUSE.COM, INC. (Exact name of registrant as specified in charter) Delaware 000-13117 22-2413505 (State or other jurisdiction of incorporation) (Commission File Number)

February 16, 2017 8-K/A

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) of the SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 6, 2017 HEALTHWAREHOUSE.COM, INC. (Exact name of registrant as specified in charter) Delaware 000-13117 22-2413505 (State or other jurisdiction of incorporation) (Commiss

February 14, 2017 SC 13G/A

HEWA / HealthWarehouse.com, Inc. / SINGER KAREN - SC 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 3)* HealthWarehouse.com, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 42227G202 (CUSIP Number) December 31, 2016 (Date of Event which

February 10, 2017 SC 13G/A

HEWA / HealthWarehouse.com, Inc. / HealthWarehouse.com, Inc. - AMENDMENT NO. 2 TO SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240.13d -1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO §240.13d -2 (Amendment No. 2)1 HealthWarehouse.com, Inc. (Name of Issuer) Common Stock, $0.001 Par Value Per Share (Title of Class of Securities) 42227G202 (CUSIP Number) December 31, 2

February 9, 2017 EX-24

POWER OF ATTORNEY

POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints each of F.

February 9, 2017 EX-24.1

POWER OF ATTORNEY

POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints each of F.

February 6, 2017 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

8-K 1 form8k020617.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) of the SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 6, 2017 HEALTHWAREHOUSE.COM, INC. (Exact name of registrant as specified in charter) Delaware 000-13117 22-2413505 (State or other jurisdiction of incorporation) (Co

January 20, 2017 EX-10.2

SEPARATION & RELEASE AGREEMENT

EX-10.2 3 v457288ex10-2.htm EXHIBIT 10.2 Exhibit 10.2 SEPARATION & RELEASE AGREEMENT This Separation and Release Agreement (“Agreement”) is between HealthWarehouse.com Inc., and any affiliate or successor thereto (collectively, the “Company”) and Jeffrey Holtmeier (“Employee”). WHEREAS, Employee has ceased his employment with the Company effective at the close of business on January 16, 2017 (the

January 20, 2017 EX-99.1

HealthWarehouse.com Inc. (

Exhibit 99.1 HealthWarehouse.com Inc. (OTCQB:HEWA), Americas? trusted online pharmacy is pleased to announce that Mr. John Pauly has been appointed Chief Operating Officer and Interim President/Chief Executive Officer, effective January 18, 2017. Mr. Pauly will report to the Board of Directors of HealthWarehouse.com. ?Mr. Pauly has built a notable career in the pharmaceutical industry, and we are

January 20, 2017 EX-10.1

EMPLOYMENT AGREEMENT

Exhibit 10.1 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (the "Agreement"), is made and entered into effective as of January 18, 2017, by and between HealthWarehouse.com, Inc., a Delaware corporation (the "Company") with its principal office and place of business located at 7107 Industrial Road, Florence, KY 41042, and John Pauly (?Employee?). RECITAL The Employee has experience in the pharmace

January 20, 2017 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 16, 2017 HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdiction (Commission File Number) (IRS Em

December 6, 2016 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

8-K 1 v4545478k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 30, 2016 HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdiction (C

December 6, 2016 EX-10.1

FOURTH AMENDMENT TO AMENDED AND RESTATED PROMISSORY NOTE

Exhibit 10.1 FOURTH AMENDMENT TO AMENDED AND RESTATED PROMISSORY NOTE THIS FOURTH AMENDMENT TO AMENDED AND RESTATED PROMISSORY NOTE (this ?Amendment?) is dated November 30, 2016, by and between HEALTHWAREHOUSE.COM, INC., a Delaware corporation, HWAREH.COM, INC., a Delaware corporation, and HOCKS.COM, INC., an Ohio corporation, jointly and severally (collectively, ?Borrower?), and MELROSE CAPITAL A

November 8, 2016 EX-10.2

Third Amendment to Amended and Restated Promissory Note dated Octohber 31, 2016 by and between HealthWarehouse.com, Inc., HWAREH.COM, Inc. and Hocks.com, Inc. and Melrose Captial Advisors, LLC *

EX-10.2 3 exhibit102.htm EXHIBIT102 Exhibit 10.2 THIRD AMENDMENT TO AMENDED AND RESTATED PROMISSORY NOTE THIS THIRD AMENDMENT TO AMENDED AND RESTATED PROMISSORY NOTE (this "Amendment") is dated October 31, 2016, by and between HEALTHWAREHOUSE.COM, INC., a Delaware corporation, HWAREH.COM, INC., a Delaware corporation, and HOCKS.COM, INC., an Ohio corporation, jointly and severally (collectively, "

November 8, 2016 10-Q

HealthWarehouse.com MAINBODY (Quarterly Report)

10-Q 1 mainbody.htm MAINBODY UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2016 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-

November 8, 2016 EX-10.1

Employment Agreement dated November 7, 2016 between the Company and Jeffrey T. Holtmeier *

Exhibit 10.1 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (the "Agreement"), is made this 4th day of November, 2016, to be effective as of September 12, 2016 (the "Effective Date"), by and between HealthWarehouse.com, Inc., a Delaware corporation (the "Company"), and Jeffrey T. Holtmeier (the "Employee"). BACKGROUND A. The Company desires to employ the Employee as its President and Chief Executi

October 14, 2016 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 11, 2016 HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdiction (Commission File Number) (IRS Em

October 14, 2016 EX-10.1

SECOND AMENDMENT TO AMENDED AND RESTATED PROMISSORY NOTE

Exhibit 10.1 SECOND AMENDMENT TO AMENDED AND RESTATED PROMISSORY NOTE THIS SECOND AMENDMENT TO AMENDED AND RESTATED PROMISSORY NOTE (this ?Amendment?) is dated October 14, 2016, by and between HEALTHWAREHOUSE.COM, INC., a Delaware corporation, HWAREH.COM, INC., a Delaware corporation, and HOCKS.COM, INC., an Ohio corporation, jointly and severally (collectively, ?Borrower?), and MELROSE CAPITAL AD

October 7, 2016 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

8-K 1 v4502278k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 4, 2016 (September 30, 2016) HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or ot

October 7, 2016 EX-10.1

AMENDMENT TO AMENDED AND RESTATED PROMISSORY NOTE

Exhibit 10.1 AMENDMENT TO AMENDED AND RESTATED PROMISSORY NOTE THIS AMENDMENT TO AMENDED AND RESTATED PROMISSORY NOTE (this "Amendment") is dated September 30, 2016, by and between HEALTHWAREHOUSE.COM, INC., a Delaware corporation, HWAREH.COM, INC., a Delaware corporation, and HOCKS.COM, INC., an Ohio corporation, jointly and severally (collectively, "Borrower"), and MELROSE CAPITAL ADVISORS, LLC,

September 15, 2016 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) of the SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 9, 2016 HEALTHWAREHOUSE.COM, INC. (Exact name of registrant as specified in charter) Delaware 000-13117 22-2413505 (State or other jurisdiction of incorporation) (Commission File Number)

September 9, 2016 8-K

Changes in Control of Registrant, Submission of Matters to a Vote of Security Holders

8-K 1 mainbody.htm MAINBODY UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C., 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 2, 2016 HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdiction (C

September 9, 2016 EX-99.9

Rx Investor Value Slate of Stockholder-Nominated Directors Elected to Board of Directors at HealthWarehouse.com Stockholders Elect All Four Nominees on RIVC's Slate to HEWA Board of Directors Based on Preliminary Voting Results

EX-99.9 2 schedule13dano7ex99-9.htm PRESS RELEASE DATED SEPTEMBER 7, 2016 EXHIBIT 99.9 Contact Michael R. Levin 847.830.1479 [email protected] FOR IMMEDIATE RELEASE Rx Investor Value Slate of Stockholder-Nominated Directors Elected to Board of Directors at HealthWarehouse.com Stockholders Elect All Four Nominees on RIVC's Slate to HEWA Board of Directors Based on Preliminary Voting Results CINCI

September 9, 2016 SC 13D/A

HEWA / HealthWarehouse.com, Inc. / Rx Investor Value Corp Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) Amendment No. 7 HealthWarehouse.com, Inc. (formerly Clacendix, Inc. / formerly Ion Networks, Inc. / formerly MicroFrame, Inc.) (Name of Issuer) Common Stock, par value $0

August 31, 2016 EX-1

Exhibit 1

Exhibit 1 RX Investor Value Corporation August 30, 2016 Dear Fellow Stockholders of HealthWarehouse.

August 31, 2016 DFAN14A

HealthWarehouse.com 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☐ Filed by a Party other than the Registrant ☑ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Statement ☑ Definitive Additional Materials ☐ Soliciting Material Pursuant to Rule 14a-12 HEALTHWAREHOUSE.

August 29, 2016 EX-1

Exhibit 1

EX-1 2 schedule14a-101082916-ex1.htm AUGUST 29 LETTER Exhibit 1 Rx Investor Value Corporation August 29, 2016 Dear Fellow HealthWarehouse.com, Inc. Shareholders: Your board of directors issued this statement in its recent letter to shareholders: "The value of your common stock has more than DOUBLED since the end of 2015 and has more than TRIPLED since the end of 2014 under your current Board of Di

August 29, 2016 DFAN14A

HealthWarehouse.com 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement ? Definitive Additional Materials ? Soliciting Material Pursuant to Rule 14a-12 HEALTHWAREHOUSE.

August 29, 2016 DEFA14A

HealthWarehouse.com MAINBODY

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State

August 29, 2016 EX-99.1

HealthWarehouse.com Projects Consumer Sales for August 2016 to be the Highest Month in Company History Consumer sales expected to top $900,000 or $10.8 million on an annualized basis

EX-99.1 2 exhibit991.htm EXHIBIT991 EXHIBIT 99.1 HealthWarehouse.com Projects Consumer Sales for August 2016 to be the Highest Month in Company History Consumer sales expected to top $900,000 or $10.8 million on an annualized basis (CINCINNATI, OH, August 29, 2016) -– HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today that it expects August 2016 to finish as the best month for consumer sales i

August 29, 2016 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 mainbody.htm MAINBODY UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C., 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 29, 2016 HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdiction (Com

August 26, 2016 DFAN14A

HealthWarehouse.com 14A

DFAN14A 1 t1600554dfan14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ¨ Filed by a Party other than the Registrant þ Check the appropriate box: ¨ Preliminary Proxy Statemen

August 26, 2016 DFAN14A

HealthWarehouse.com 14A

DFAN14A 1 t1600554dfan14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ¨ Filed by a Party other than the Registrant þ Check the appropriate box: ¨ Preliminary Proxy Statemen

August 25, 2016 EX-2

Item 4. Purpose of the Transaction

EX-2 3 t1600545ex-2.htm EXHIBIT 2 Exhibit 2 Item 4. Purpose of the Transaction Item 4 of Schedule 13D is amended by adding the following: The following is added to the end of Item 4 of Schedule 13D: On August 25, 2016 and August 24, 2016, RIVC issued the press releases attached hereto and incorporated herein by reference as Exhibit 99.8.

August 25, 2016 DFAN14A

HealthWarehouse.com DEFINITIVE ADDITIONAL MATERIALS

DFAN14A 1 t1600545dfan14a.htm DEFINITIVE ADDITIONAL MATERIALS UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ¨ Filed by a Party other than the Registrant þ Check the appropriate b

August 25, 2016 EX-1

Rx Investor Value Corporation Receives Another Third- Party Endorsement in Board Solicitation Glass Lewis Joins ISS in Also Endorsing Stockholder-Driven Efforts to Transform HealthWarehouse.com, Inc. Urges Stockholders to Support RIVC on BLUE proxy c

Exhibit 1 Rx Investor Value Corporation Contact Michael R. Levin 847.830.1479 [email protected] Rx Investor Value Corporation Receives Another Third- Party Endorsement in Board Solicitation Glass Lewis Joins ISS in Also Endorsing Stockholder-Driven Efforts to Transform HealthWarehouse.com, Inc. Urges Stockholders to Support RIVC on BLUE proxy card; urges stockholders to NOT support current board

August 25, 2016 EX-24.1

POWER OF ATTORNEY

POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints each of Thomas W.

August 25, 2016 EX-24.1

POWER OF ATTORNEY

POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints each of Thomas W.

August 25, 2016 EX-24.1

POWER OF ATTORNEY

POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints each of Thomas W.

August 25, 2016 EX-24.1

POWER OF ATTORNEY

POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints each of Thomas W.

August 25, 2016 EX-99.8

Rx Investor Value Corporation Receives Another Third- Party Endorsement in Board Solicitation Glass Lewis Joins ISS in Also Endorsing Stockholder-Driven Efforts to Transform HealthWarehouse.com, Inc. Urges Stockholders to Support RIVC on BLUE proxy c

EX-99.8 2 t1600546ex99-8.htm EXHIBIT 99.8 Exhibit 99.8 Rx Investor Value Corporation Contact Michael R. Levin 847.830.1479 [email protected] Rx Investor Value Corporation Receives Another Third- Party Endorsement in Board Solicitation Glass Lewis Joins ISS in Also Endorsing Stockholder-Driven Efforts to Transform HealthWarehouse.com, Inc. Urges Stockholders to Support RIVC on BLUE proxy card; ur

August 25, 2016 SC 13D/A

HEWA / HealthWarehouse.com, Inc. / Rx Investor Value Corp - SCHEDULE 13D (AMENDMENT NO. 6) Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) Amendment No. 6 HealthWarehouse.com, Inc. (formerly Clacendix, Inc. / formerly Ion Networks, Inc. / formerly MicroFrame, Inc.) (Name of Issuer) Common Stock, par value $0

August 25, 2016 EX-99.8

Rx Investor Value Corporation Receives Another Third- Party Endorsement in Board Solicitation Glass Lewis Joins ISS in Also Endorsing Stockholder-Driven Efforts to Transform HealthWarehouse.com, Inc. Urges Stockholders to Support RIVC on BLUE proxy c

EX-99.8 2 t1600546ex99-8.htm EXHIBIT 99.8 Exhibit 99.8 Rx Investor Value Corporation Contact Michael R. Levin 847.830.1479 [email protected] Rx Investor Value Corporation Receives Another Third- Party Endorsement in Board Solicitation Glass Lewis Joins ISS in Also Endorsing Stockholder-Driven Efforts to Transform HealthWarehouse.com, Inc. Urges Stockholders to Support RIVC on BLUE proxy card; ur

August 25, 2016 SC 13D/A

HEWA / HealthWarehouse.com, Inc. / Rx Investor Value Corp - SCHEDULE 13D (AMENDMENT NO. 6) Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) Amendment No. 6 HealthWarehouse.com, Inc. (formerly Clacendix, Inc. / formerly Ion Networks, Inc. / formerly MicroFrame, Inc.) (Name of Issuer) Common Stock, par value $0

August 24, 2016 EX-1

Exhibit 1

EX-1 2 schedule14a-101082416ex-1.htm AUGUST 24 LETTER Exhibit 1 August 24, 2016 To: Stockholders of HealthWarehouse.com, Inc. (HEWA) From: Rx Investor Value Corporation (RIVC) Re: Board of Directors Distracts Stockholders from Core Issues at Stake in Election RIVC has joined with other stockholders, who combined represent over one-third of the outstanding shares of HEWA, to promote constructive ch

August 24, 2016 DFAN14A

HealthWarehouse.com 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement ? Definitive Additional Materials ? Soliciting Material Pursuant to Rule 14a-12 HEALTHWAREHOUSE.

August 24, 2016 DFAN14A

HealthWarehouse.com 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement ? Definitive Additional Materials ? Soliciting Material Pursuant to Rule 14a-12 HEALTHWAREHOUSE.

August 24, 2016 EX-2

Exhibit 2

EX-2 3 schedule14a-101082416ex-2.htm ITEM 4. PURPOSE OF THE TRANSACTION Exhibit 2 Item 4. Purpose of the Transaction Item 4 of Schedule 13D is amended by adding the following: The following is added to the end of Item 4 of Schedule 13D: On August 24, 2016, RIVC sent a letter (the "August 24 Letter") to stockholders of the Issuer.

August 24, 2016 EX-1

Exhibit 1

EX-1 2 schedule14a-101082416ex-1.htm AUGUST 24 LETTER Exhibit 1 August 24, 2016 To: Stockholders of HealthWarehouse.com, Inc. (HEWA) From: Rx Investor Value Corporation (RIVC) Re: Board of Directors Distracts Stockholders from Core Issues at Stake in Election RIVC has joined with other stockholders, who combined represent over one-third of the outstanding shares of HEWA, to promote constructive ch

August 24, 2016 EX-2

Exhibit 2

EX-2 3 schedule14a-101082416ex-2.htm ITEM 4. PURPOSE OF THE TRANSACTION Exhibit 2 Item 4. Purpose of the Transaction Item 4 of Schedule 13D is amended by adding the following: The following is added to the end of Item 4 of Schedule 13D: On August 24, 2016, RIVC sent a letter (the "August 24 Letter") to stockholders of the Issuer.

August 24, 2016 DFAN14A

HealthWarehouse.com DEFINITIVE ADDITIONAL MATERIALS

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ¨ Filed by a Party other than the Registrant þ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy Statement þ Definitive Additional Materials ¨ Soliciting Material Pursuant to Rule 14a-12 HEALTHWAREHOUSE.

August 24, 2016 DFAN14A

HealthWarehouse.com DEFINITIVE ADDITIONAL MATERIALS

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ¨ Filed by a Party other than the Registrant þ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy Statement þ Definitive Additional Materials ¨ Soliciting Material Pursuant to Rule 14a-12 HEALTHWAREHOUSE.

August 24, 2016 SC 13D/A

HEWA / HealthWarehouse.com, Inc. / Rx Investor Value Corp - AMENDMENT NO. 5 TO SCHEDULE 13D. Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) Amendment No. 5 HealthWarehouse.com, Inc. (formerly Clacendix, Inc. / formerly Ion Networks, Inc. / formerly MicroFrame, Inc.) (Name of Issuer) Common Stock, par value $0

August 24, 2016 EX-99.7

August 24, 2016

EXHIBIT 99.7 August 24, 2016 To: Stockholders of HealthWarehouse.com, Inc. (HEWA) From: Rx Investor Value Corporation (RIVC) Re: Board of Directors Distracts Stockholders from Core Issues at Stake in Election RIVC has joined with other stockholders, who combined represent over one-third of the outstanding shares of HEWA, to promote constructive change at our company. RIVC writes to alert you to th

August 24, 2016 EX-99.7

August 24, 2016

EXHIBIT 99.7 August 24, 2016 To: Stockholders of HealthWarehouse.com, Inc. (HEWA) From: Rx Investor Value Corporation (RIVC) Re: Board of Directors Distracts Stockholders from Core Issues at Stake in Election RIVC has joined with other stockholders, who combined represent over one-third of the outstanding shares of HEWA, to promote constructive change at our company. RIVC writes to alert you to th

August 24, 2016 SC 13D/A

HEWA / HealthWarehouse.com, Inc. / Rx Investor Value Corp - AMENDMENT NO. 5 TO SCHEDULE 13D. Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) Amendment No. 5 HealthWarehouse.com, Inc. (formerly Clacendix, Inc. / formerly Ion Networks, Inc. / formerly MicroFrame, Inc.) (Name of Issuer) Common Stock, par value $0

August 23, 2016 DEFA14A

HealthWarehouse.com MAINBODY

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State

August 23, 2016 DEFA14A

HealthWarehouse.com MAINBODY

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State

August 22, 2016 EX-1

Exhibit 1

Exhibit 1 August 22, 2016 Via e-mail HealthWarehouse.com, Inc. Corporate Secretary 7107 Industrial Road Florence, Kentucky 41042 Re: Demand to Inspect Books and Records Rx Investor Value Corporation ("RIVC") is the record and beneficial owner of at least 100 shares of common stock, par value $0.001 per share, of HealthWarehouse.com, Inc. ("HEWA" or the "Company"). Please refer Exhibit A hereto for

August 22, 2016 EX-2

Exhibit 2

Exhibit 2 Item 4. Purpose of the Transaction Item 4 of Schedule 13D is amended by adding the following: The following is added to the end of Item 4 of Schedule 13D: On August 22, 2016, RIVC sent a letter (the " August 22 Letter") to the Issuer supplementing its August 5, 2016 letter (the " August 5 Letter") in which it demanded to inspect certain books and records of the Issuer. The August 22 Lett

August 22, 2016 EX-2

Exhibit 2

Exhibit 2 Item 4. Purpose of the Transaction Item 4 of Schedule 13D is amended by adding the following: The following is added to the end of Item 4 of Schedule 13D: On August 22, 2016, RIVC sent a letter (the " August 22 Letter") to the Issuer supplementing its August 5, 2016 letter (the " August 5 Letter") in which it demanded to inspect certain books and records of the Issuer. The August 22 Lett

August 22, 2016 DFAN14A

HealthWarehouse.com 14A

DFAN14A 1 schedule14a-101082216.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☐ Filed by a Party other than the Registrant ☑ Check the appropriate box: ☐ Preliminary Proxy St

August 22, 2016 DFAN14A

HealthWarehouse.com 14A

DFAN14A 1 schedule14a-101082216.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☐ Filed by a Party other than the Registrant ☑ Check the appropriate box: ☐ Preliminary Proxy St

August 22, 2016 EX-1

Exhibit 1

Exhibit 1 August 22, 2016 Via e-mail HealthWarehouse.com, Inc. Corporate Secretary 7107 Industrial Road Florence, Kentucky 41042 Re: Demand to Inspect Books and Records Rx Investor Value Corporation ("RIVC") is the record and beneficial owner of at least 100 shares of common stock, par value $0.001 per share, of HealthWarehouse.com, Inc. ("HEWA" or the "Company"). Please refer Exhibit A hereto for

August 22, 2016 SC 13D/A

HEWA / HealthWarehouse.com, Inc. / Rx Investor Value Corp - AMENDMENT NO. 4 TO SCHEDULE 13D. Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) Amendment No. 4 HealthWarehouse.com, Inc. (formerly Clacendix, Inc. / formerly Ion Networks, Inc. / formerly MicroFrame, Inc.) (Name of Issuer) Common Stock, par value $0

August 22, 2016 EX-99.6

August 22, 2016

EX-99.6 2 schedule13dano4ex99-6.htm LETTER FROM RX INVESTOR VALUE CORPORATION TO HEALTHWAREHOUSE.COM, INC. DATED AUGUST 22, 2016 EXHIBIT 99.6 August 22, 2016 Via e-mail HealthWarehouse.com, Inc. Corporate Secretary 7107 Industrial Road Florence, Kentucky 41042 Re: Demand to Inspect Books and Records Rx Investor Value Corporation ("RIVC") is the record and beneficial owner of at least 100 shares of

August 22, 2016 EX-99.6

August 22, 2016

EX-99.6 2 schedule13dano4ex99-6.htm LETTER FROM RX INVESTOR VALUE CORPORATION TO HEALTHWAREHOUSE.COM, INC. DATED AUGUST 22, 2016 EXHIBIT 99.6 August 22, 2016 Via e-mail HealthWarehouse.com, Inc. Corporate Secretary 7107 Industrial Road Florence, Kentucky 41042 Re: Demand to Inspect Books and Records Rx Investor Value Corporation ("RIVC") is the record and beneficial owner of at least 100 shares of

August 22, 2016 SC 13D/A

HEWA / HealthWarehouse.com, Inc. / Rx Investor Value Corp - AMENDMENT NO. 4 TO SCHEDULE 13D. Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) Amendment No. 4 HealthWarehouse.com, Inc. (formerly Clacendix, Inc. / formerly Ion Networks, Inc. / formerly MicroFrame, Inc.) (Name of Issuer) Common Stock, par value $0

August 19, 2016 DEFC14A

HealthWarehouse.com DEFC14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ¨ Filed by a Party other than the Registrant þ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) þ Definitive Proxy Statement ¨ Definitive Additional Materials ¨ Soliciting Material Pursuant to Rule 14a-12 HEALTHWAREHOUSE.

August 19, 2016 DEFC14A

HealthWarehouse.com DEFC14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ¨ Filed by a Party other than the Registrant þ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) þ Definitive Proxy Statement ¨ Definitive Additional Materials ¨ Soliciting Material Pursuant to Rule 14a-12 HEALTHWAREHOUSE.

August 19, 2016 DEFA14A

HealthWarehouse.com MAINBODY

DEFA14A 1 mainbody.htm MAINBODY UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6

August 19, 2016 DEFA14A

HealthWarehouse.com MAINBODY

DEFA14A 1 mainbody.htm MAINBODY UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6

August 19, 2016 8-K

Financial Statements and Exhibits

mainbody.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C., 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 19, 2016 (August 15, 2016) HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdiction (

August 19, 2016 EX-10.1

Amended and Restated Promissory Note dated August 15, 2016 by and between HealthWarehouse.com, Inc., HWAREH.COM, Inc. and Hocks.com, Inc. and Melrose Capital Advisors, LLC

EX-10.1 2 exhibit101.htm EXHIBIT101 EXHIBIT 10.1 AMENDED AND RESTATED PROMISSORY NOTE $1,200,000.00 August 15, 2016 ("Effective Date") FOR VALUE RECEIVED, the undersigned, HEALTHWAREHOUSE.COM, INC., a Delaware corporation, HWAREH.COM, INC., a Delaware corporation, and HOCKS.COM, INC., an Ohio corporation, jointly and severally, (collectively, "Borrower"), with an address at 7107 Industrial Road, F

August 19, 2016 8-K

Financial Statements and Exhibits

mainbody.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C., 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 19, 2016 (August 15, 2016) HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdiction (

August 19, 2016 EX-10.1

Amended and Restated Promissory Note dated August 15, 2016 by and between HealthWarehouse.com, Inc., HWAREH.COM, Inc. and Hocks.com, Inc. and Melrose Capital Advisors, LLC

EX-10.1 2 exhibit101.htm EXHIBIT101 EXHIBIT 10.1 AMENDED AND RESTATED PROMISSORY NOTE $1,200,000.00 August 15, 2016 ("Effective Date") FOR VALUE RECEIVED, the undersigned, HEALTHWAREHOUSE.COM, INC., a Delaware corporation, HWAREH.COM, INC., a Delaware corporation, and HOCKS.COM, INC., an Ohio corporation, jointly and severally, (collectively, "Borrower"), with an address at 7107 Industrial Road, F

August 19, 2016 PRRN14A

HealthWarehouse.com PRRN14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement ? Definitive Additional Materials ? Soliciting Material Pursuant to Rule 14a-12 HEALTHWAREHOUSE.

August 19, 2016 PRRN14A

HealthWarehouse.com PRRN14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement ? Definitive Additional Materials ? Soliciting Material Pursuant to Rule 14a-12 HEALTHWAREHOUSE.

August 17, 2016 PRRN14A

HealthWarehouse.com PRRN14A

PRRN14A 1 t85253cprrn14a.htm PRRN14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ¨ Filed by a Party other than the Registrant þ Check the appropriate box: þ Preliminary Proxy S

August 15, 2016 EX-1

EX-1

EXCHANGE AGREEMENT THIS EXCHANGE AGREEMENT (the "Agreement"), dated this 28th day of July 2016, is by and between HealthWarehouse.

August 15, 2016 SC 13D

HEWA / HealthWarehouse.com, Inc. / Reilly Timothy E - SCHEDULE 13D Activist Investment

10622618v1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* HealthWarehouse.com, Inc. (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of Securities) 42227G02 (CUSIP Number) Timothy E. Reilly 1085 Gulf of Mexico Drive #602 Longboat Key, Florida 34228 (513) 703-5168 (Name, Addres

August 15, 2016 EX-1

EX-1

EXCHANGE AGREEMENT THIS EXCHANGE AGREEMENT (the "Agreement"), dated this 28th day of July 2016, is by and between HealthWarehouse.

August 12, 2016 DEFA14A

HealthWarehouse.com MAINBODY

DEFA14A 1 mainbody.htm MAINBODY UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6

August 12, 2016 EX-1

Exhibit 1

EX-1 2 schedule14a-12081216ex1.htm ITEM 4 DISCLOSURE Exhibit 1 Item 4. Purpose of the Transaction Item 4 of Schedule 13D is amended by adding the following: On August 12, 2016, Rx Investor Value Corporation filed with the Securities and Exchange Commission preliminary proxy materials containing the following statements: "Our plan is to … infuse capital into the company to settle vendor claims and

August 12, 2016 DFAN14A

HealthWarehouse.com SCHEDULE 14A-12 SOLICITING MATERIAL

DFAN14A 1 schedule14a-12081216.htm SCHEDULE 14A-12 SOLICITING MATERIAL UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☐ Filed by a Party other than the Registrant ☑ Check the appr

August 12, 2016 PRRN14A

HealthWarehouse.com PRELIMINARY PROXY MATERIALS

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement ? Definitive Additional Materials ? Soliciting Material Pursuant to Rule 14a-12 HEALTHWAREHOUSE.

August 12, 2016 SC 13D/A

HEWA / HealthWarehouse.com, Inc. / Rx Investor Value Corp - AMENDMENT NO. 3 TO SCHEDULE 13D Activist Investment

SC 13D/A 1 schedule13dano3.htm AMENDMENT NO. 3 TO SCHEDULE 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) Amendment No. 3 HealthWarehouse.com, Inc. (formerly Clacendix, Inc. / formerly Ion Networks, Inc. / formerl

August 11, 2016 EX-99.1

HealthWarehouse.com Reports 51.2% Sales Growth In Consumer Business Year Over Year New Customers Grow 140% and Core Prescription Sales Grow Record 49.3%

EX-99.1 2 exhibit991.htm EXHIBIT991 EXHIBIT 99.1 HealthWarehouse.com Reports 51.2% Sales Growth In Consumer Business Year Over Year New Customers Grow 140% and Core Prescription Sales Grow Record 49.3% (CINCINNATI, OH, August 9, 2016) - HealthWarehouse.com, Inc. (OTCQB:HEWA), the only VIPPS & Vet-VIPPS accredited online pharmacy licensed in all 50 states, announced financial results for the quarte

August 11, 2016 8-K

HealthWarehouse.com MAINBODY (Current Report/Significant Event)

mainbody.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C., 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2016 (August 9, 2016) HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdiction (C

August 11, 2016 EX-2

EXHIBIT 2

EXHIBIT 2 Item 4. Purpose of the Transaction Item 4 of Schedule 13D is amended by adding the following: On August 10, 2016, Rx Investor Value Corporation sent a letter (the "Letter") to the Issuer expressing its concerns related to the Issuer's recent announcement to "hire an investment banker to evaluate the board's options to maximize stockholder value." The Letter states that it is "difficult t

August 11, 2016 EX-1

EXHIBIT 1

EXHIBIT 1 Rx Investor Value Corporation August 10, 2016 Via e-mail HealthWarehouse.

August 11, 2016 DFAN14A

HealthWarehouse.com SCHEDULE 14A-12 SOLICITING MATERIAL

DFAN14A 1 schedule14a-12081116.htm SCHEDULE 14A-12 SOLICITING MATERIAL UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☐ Filed by a Party other than the Registrant ☑ Check the appr

August 11, 2016 EX-99.5

Rx Investor Value Corporation

EXHIBIT 99.5 Rx Investor Value Corporation August 10, 2016 Via e-mail HealthWarehouse.com, Inc. Board of Directors 7107 Industrial Road Florence, Kentucky 41042 Re: Upcoming Annual Stockholder Meeting As you know, Rx Investor Value Corporation ("RIVC") and other stockholders who combined own over 40% of the outstanding shares of HEWA have joined together to promote constructive change at our compa

August 11, 2016 SC 13D/A

HEWA / HealthWarehouse.com, Inc. / Rx Investor Value Corp - AMENDMENT NO. 2 TO SCHEDULE 13D Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) Amendment No. 2 HealthWarehouse.com, Inc. (formerly Clacendix, Inc. / formerly Ion Networks, Inc. / formerly MicroFrame, Inc.) (Name of Issuer) Common Stock, par value $0

August 9, 2016 SC 13D/A

HEWA / HealthWarehouse.com, Inc. / Rx Investor Value Corp - AMENDMENT NO. 1 TO SCHEDULE 13D Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) Amendment No. 1 HealthWarehouse.com, Inc. (formerly Clacendix, Inc. / formerly Ion Networks, Inc. / formerly MicroFrame, Inc.) (Name of Issuer) Common Stock, par value $0

August 9, 2016 EX-99.4

Rx Investor Value Corporation

EXHIBIT 99.4 Rx Investor Value Corporation August 5, 2016 Via e-mail HealthWarehouse.com, Inc. Corporate Secretary 7107 Industrial Road Florence, Kentucky 41042 Re: Demand to Inspect Books and Records Rx Investor Value Corporation ("RIVC") is the record and beneficial owner of at least 100 shares of common stock, par value $0.001 per share, of HealthWarehouse.com, Inc. ("HEWA"). Please refer Exhib

August 8, 2016 8-K

Financial Statements and Exhibits, Other Events

mainbody.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2016 HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdiction (Commission File Numb

August 8, 2016 EX-99.1

HealthWarehouse.com To Hire Investment Banker To Maximize Shareholder Value Company Looks To Take Advantage of Current Healthcare Consolidation Trends

EX-99.1 2 exhibit991.htm EXHIBIT991 EXHIBIT 99.1 HealthWarehouse.com To Hire Investment Banker To Maximize Shareholder Value Company Looks To Take Advantage of Current Healthcare Consolidation Trends (CINCINNATI, OH, August 8, 2016) - -HealthWarehouse.com, Inc. (OTCQB: HEWA), the only VIPPS & Vet-VIPPS accredited online pharmacy licensed in all 50 states, today announced that it intends to hire an

August 8, 2016 EX-99.1

Press Release dated August 8, 2016 announcing the Company's intention to hire an investment banking firm.

EXHIBIT 99.1 HealthWarehouse.com To Hire Investment Banker To Maximize Shareholder Value Company Looks To Take Advantage of Current Healthcare Consolidation Trends (CINCINNATI, OH, August 8, 2016) - -HealthWarehouse.com, Inc. (OTCQB: HEWA), the only VIPPS & Vet-VIPPS accredited online pharmacy licensed in all 50 states, today announced that it intends to hire an investment banking firm to explore

August 8, 2016 DEFA14A

HealthWarehouse.com MAINBODY

DEFA14A 1 mainbody.htm MAINBODY UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2016 HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdiction (C

August 8, 2016 10-Q

HealthWarehouse.com MAINBODY (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2016 ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-13117 HealthWarehouse.com, Inc. (E

August 5, 2016 PREC14A

HealthWarehouse.com PRELIMINARY SCHEDULE 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement ? Definitive Additional Materials ? Soliciting Material Pursuant to Rule 14a-12 HEALTHWAREHOUSE.

August 3, 2016 EX-99.1

HealthWarehouse.com Reduces Its Liabilities By Nearly $700,000 Significant Improvement to Stockholders' Equity and Reduction in Current Liabilities by 14.6%

EX-99.1 3 exhibit991.htm EXHIBIT991 EXHIBIT 99.1 HealthWarehouse.com Reduces Its Liabilities By Nearly $700,000 Significant Improvement to Stockholders' Equity and Reduction in Current Liabilities by 14.6% (CINCINNATI, OH, August 3, 2016) - HealthWarehouse.com, Inc. (OTCQB:HEWA), the only VIPPS & Vet-VIPPS accredited online and mail-order pharmacy licensed in all 50 states, has entered into an agr

August 3, 2016 EX-10.1

Exchange Agreement, dated July 28, 2016, by and between HealthWarehouse.com, Inc. and Dellave Holdings, Inc.

EXHIBIT 10.1 EXCHANGE AGREEMENT THIS EXCHANGE AGREEMENT (the "Agreement"), dated this 28 th day of July 2016, is by and between HealthWarehouse.com, Inc. (the "Company") and Dellave Holdings LLC ("Dellave"). The Company and Dellave are collectively referred to herein as the "Parties." RECITALS WHEREAS, Dellave holds accounts payable that are liabilities of the Company; WHEREAS, the Company's total

August 3, 2016 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 3, 2016 (July 28, 2016) HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdiction (Commission File N

August 3, 2016 DEF 14A

HealthWarehouse.com MAINBODY

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State

August 2, 2016 EX-7.3

Consent of Mark Scott

Exhibit 7.3 July 25, 2016 Via e-mail and Courier HealthWarehouse.com, Inc. 7107 Industrial Road Florence, KY 41042 Attention: Acting Secretary Re: Notice of Director Nominees to be Elected at 2016 Annual Meeting of Stockholders Ladies and Gentlemen: This letter supplements the Notice, dated June 27, 2016 (the “Notice”), sent to you by Rx Investor Value Corporation, a Delaware corporation (“RIVC”),

August 2, 2016 SC 13D

HEWA / HealthWarehouse.com, Inc. / Rx Investor Value Corp Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) HealthWarehouse.com, Inc. (formerly Clacendix, Inc. / formerly Ion Networks, Inc. / formerly MicroFrame, Inc.) (Name of Issuer) Common Stock, par value $0.001 (Title of C

August 2, 2016 EX-7.1

JOINT FILING AGREEMENT

EX-7.1 2 exh7-1.htm Exhibit 7.1 JOINT FILING AGREEMENT The parties listed below agree that the Schedule 13D to which this agreement is attached as an exhibit, and all further amendments thereto, shall be filed on behalf of each of them. This Agreement is intended to satisfy Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended. This Agreement may be executed in any number of count

August 2, 2016 EX-7.2

Evidence of Share Ownership [intentionally omitted]

Exhibit 7.2 June 27, 2016 Via e-mail and courier HealthWarehouse.com, Inc. Acting Secretary 7107 Industrial Road Florence, Kentucky 41042 RE: Notice of Director Nominees to be Elected at 2016 Annual Meeting of Stockholders This Notice is sent on behalf of Rx Investor Value Corporation, a Delaware corporation (“RIVC”), to provide notice of RIVC’s intent to nominate director candidates for election

August 1, 2016 PRER14A

HealthWarehouse.com MAINBODY

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State

August 1, 2016 CORRESP

HealthWarehouse.com ESP

Law Offices Silver, Freedman, Taff & Tiernan LLP A Limited Liability Partnership Including Professional Corporations 3299 K STREET, N.

July 22, 2016 PREC14A

HealthWarehouse.com MAINBODY

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: x Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy State

July 22, 2016 CORRESP

HealthWarehouse.com ESP

CORRESP 1 filename1.htm Law Offices Silver, Freedman, Taff & Tiernan LLP A Limited Liability Partnership Including Professional Corporations 3299 K STREET, N.W., SUITE 100 WASHINGTON, D.C. 20007 (202) 295-4500 WWW.SFTTLAW.COM TELECOPIER NUMBER (202) 337-5502 PHONE NUMBER (202) 295-4516 [email protected] July 22, 2016 Via Edgar Division of Corporation Finance Securities and Exchange Commission 100

July 15, 2016 8-K

HealthWarehouse.com MAINBODY (Current Report/Significant Event)

mainbody.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 15, 2016 (July 14, 2016) HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdiction (Commi

July 1, 2016 8-K

HealthWarehouse.com MAINBODY (Current Report/Significant Event)

mainbody.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 1, 2016 (June 29, 2016) HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdiction (Commis

July 1, 2016 EX-10.1

Amendment to Amended and Restated Promissory Note dated June 29, 2016 by and between HealthWarehouse.com, Inc., HWAREH.COM, Inc. and Hocks.com, Inc. and Melrose Capital Advisors, LLC.

EXHIBIT 10.1 AMENDMENT TO AMENDED AND RESTATED PROMISSORY NOTE THIS AMENDMENT TO AMENDED AND RESTATED PROMISSORYNOTE (this "Amendment") is dated June 29, 2016, to be effective as of May 31, 2016,by and between HEALTHWAREHOUSE.COM, INC., a Delaware corporation, HWAREH.COM, INC., a Delaware corporation, and HOCKS.COM, INC., an Ohio corporation, jointly and severally, (collectively, "Borrower"), and

June 17, 2016 8-K

HealthWarehouse.com MAINBODY (Current Report/Significant Event)

mainbody.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 17, 2016 (June 16, 2016) HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdiction (Commi

June 6, 2016 EX-99.1

LD MICRO INVITATIONAL 2016LUXE SUNSET BEL AIR HOTEL, LOS ANGELES, CAJUNE 7, 2016 This presentation may contain forward-looking statements regarding future events or the future financial and operational performance of HealthWarehouse.com. Words such a

EXHIBIT 99.1 LD MICRO INVITATIONAL 2016LUXE SUNSET BEL AIR HOTEL, LOS ANGELES, CAJUNE 7, 2016 This presentation may contain forward-looking statements regarding future events or the future financial and operational performance of HealthWarehouse.com. Words such as ?targets,? ?expects,? ?believes,? ?anticipates,? ?intends,? ?may,? ?will,? ?plan,? ?continue,? ?forecast,? ?remains,? ?would,? ?should,

June 6, 2016 8-K

HealthWarehouse.com MAINBODY (Current Report/Significant Event)

mainbody.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 6, 2016 HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdiction (Commission File Number

June 6, 2016 EX-99.2

HealthWarehouse.com to Present at the LD Micro Invitational

EX-99.2 3 exhibit992.htm EXHIBIT992 EXHIBIT 99.2 HealthWarehouse.com to Present at the LD Micro Invitational (LOS ANGELES, CA, June 6, 2016) - HealthWarehouse.com, Inc. (OTCQB:HEWA), the only VIPPS accredited online and mail-order pharmacy licensed in all 50 states, announced today that it will be presenting at the 6th annual LD Micro Invitational on Tuesday, June 7 at 2pm PST. Lalit Dhadphale, Pr

May 31, 2016 EX-99.2

HealthWarehouse.com to Present at the 2016 Marcum MicroCap Conference

EXHIBIT 99.2 HealthWarehouse.com to Present at the 2016 Marcum MicroCap Conference (NEW YORK, NY, May 31, 2016) - HealthWarehouse.com, Inc. (OTCQB:HEWA), the only VIPPS accredited online and mail-order pharmacy licensed in all 50 states, announced today that it will present at the 2016 Marcum MicroCap Conference on Wednesday, June, 1, 2016, in New York City at the Grand Hyatt Hotel. The Company's

May 31, 2016 EX-99.1

MARCUM MICROCAP CONFERENCE 2016GRAND HYATT, NEW YORK, NYJUNE 1, 2016 This presentation may contain forward-looking statements regarding future events or the future financial and operational performance of HealthWarehouse.com. Words such as “targets,”

EXHIBIT 99.1 MARCUM MICROCAP CONFERENCE 2016GRAND HYATT, NEW YORK, NYJUNE 1, 2016 This presentation may contain forward-looking statements regarding future events or the future financial and operational performance of HealthWarehouse.com. Words such as ?targets,? ?expects,? ?believes,? ?anticipates,? ?intends,? ?may,? ?will,? ?plan,? ?continue,? ?forecast,? ?remains,? ?would,? ?should,? ?projected

May 31, 2016 8-K

Financial Statements and Exhibits

8-K 1 mainbody.htm MAINBODY UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 31, 2016 HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdiction (Commiss

May 31, 2016 8-K

Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 31, 2016 HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdiction (Commission File Number) (IRS Employ

May 31, 2016 EX-99.1

SEETHRUEQUITY MICROCAP INVESTOR CONFERENCE 2016CONVENE CONFERENCE CENTER, NEW YORK, NYMAY 31, 2016 This presentation may contain forward-looking statements regarding future events or the future financial and operational performance of HealthWarehouse

EXHIBIT 99.1 SEETHRUEQUITY MICROCAP INVESTOR CONFERENCE 2016CONVENE CONFERENCE CENTER, NEW YORK, NYMAY 31, 2016 This presentation may contain forward-looking statements regarding future events or the future financial and operational performance of HealthWarehouse.com. Words such as ?targets,? ?expects,? ?believes,? ?anticipates,? ?intends,? ?may,? ?will,? ?plan,? ?continue,? ?forecast,? ?remains,?

May 31, 2016 EX-99.2

7107 Industrial Rd. • Florence, KY 41042 Tel: (800) 748-7001 • Fax: (888) 870-2808 • www.HealthWarehouse.com

EXHIBIT 99.2 HealthWarehouse.com To Present at the 5 th Annual SeeThruEquity Microcap Investor Conference in New York City on May 31, 2016 (NEW YORK, NY May 27, 2016) - HealthWarehouse.com, Inc. (OTCQB:HEWA), the only VIPPS accredited online pharmacy licensed in all 50 states, today announced that the company will present at the 5 th Annual SeeThruEquity Microcap Investor Conference at Convene on

May 24, 2016 8-K

HealthWarehouse.com MAINBODY (Current Report/Significant Event)

mainbody.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 24, 2016 (May 23, 2016) HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdiction (Commiss

May 24, 2016 EX-99.1

StockNewsNow.com Publishes NewSNNLive Video Interview with HealthWarehouse.com, Inc.

EXHIBIT 99.1 StockNewsNow.com Publishes NewSNNLive Video Interview with HealthWarehouse.com, Inc. Los Angeles, CA ? StockNewsNow.com, The Official MicroCap News Source?, today published an SNNLive Video Interview with Lalit Dhadphale, President and CEO of HealthWarehouse.com, Inc. (OTCQB: HEWA), the only VIPPS accredited online and mail-order pharmacy licensed in all 50 states , according to the c

May 24, 2016 8-K

HealthWarehouse.com MAINBODY (Current Report/Significant Event)

mainbody.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 24, 2016 (May 13, 2016) HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdiction (Commiss

May 17, 2016 8-K

HealthWarehouse.com MAINBODY (Current Report/Significant Event)

mainbody.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 17, 2016 HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdiction (Commission File Number

May 17, 2016 EX-99.1

HealthWarehouse.com Reports 45.6% Sales Growth Year Over Year Core Prescription Sales Grow 63.3% and New Customers Grow 198.5%

EXHIBIT 99.1 HealthWarehouse.com Reports 45.6% Sales Growth Year Over Year Core Prescription Sales Grow 63.3% and New Customers Grow 198.5% (CINCINNATI, OH, May 17, 2016) - HealthWarehouse.com, Inc. (OTCQB:HEWA), the only VIPPS accredited online and mail-order pharmacy licensed in all 50 states, announced financial results for the quarter ended March 31, 2016 on Thursday, May 13, 2016. For the qua

May 12, 2016 10-Q

HealthWarehouse.com MAINBODY (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2016 ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-13117 HealthWarehouse.com, Inc. (

May 12, 2016 EX-10.1

Employment Agreement dated May 9, 2016 between the Company and Lalit Dhadphale.*

EX-10.1 2 exhibit101.htm EXHIBIT101 Exhibit 10.1 EMPLOYMENT AGREEMENT EMPLOYMENT AGREEMENT, entered into as of May 9, 2016 (the "Agreement"), by and between HealthWarehouse.com, Inc., a Delaware corporation (the "Company"), and Lalit Dhadphale (the "Employee"). W I T N E S S E T H: WHEREAS, the Company desires to employ the Employee as its President and Chief Executive Officer so that it will have

May 4, 2016 EX-99.2

HealthWarehouse.com to Present at the 3rd Annual Growth Capital Expo Microcap Investor Conference in Las Vegas, NV

EX-99.2 3 exhibit992.htm EXHIBIT992 EXHIBIT 99.2 HealthWarehouse.com to Present at the 3rd Annual Growth Capital Expo Microcap Investor Conference in Las Vegas, NV (LAS VEGAS, NV, May 3, 2016) - HealthWarehouse.com, Inc. (OTCQB:HEWA), the only VIPPS accredited online pharmacy licensed in all 50 states, will present at the 3rd annual Growth Capital Expo MicroCap Investor Conference, held on May 3rd

May 4, 2016 EX-99.1

GROWTH CAPITAL EXPO 2016CAESAR’S PALACE, LAS VEGAS, NVMAY 3 - 5, 2016 This presentation may contain forward-looking statements regarding future events or the future financial and operational performance of HealthWarehouse.com. Words such as “targets,

EXHIBIT 99.1 GROWTH CAPITAL EXPO 2016CAESAR’S PALACE, LAS VEGAS, NVMAY 3 - 5, 2016 This presentation may contain forward-looking statements regarding future events or the future financial and operational performance of HealthWarehouse.com. Words such as “targets,” “expects,” “believes,” “anticipates,” “intends,” “may,” “will,” “plan,” “continue,” “forecast,” “remains,” “would,” “should,” “projecte

May 4, 2016 8-K

HealthWarehouse.com MAINBODY (Current Report/Significant Event)

mainbody.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2016 (May 4, 2016) HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdiction (Commissio

May 2, 2016 8-K

HealthWarehouse.com MAINBODY (Current Report/Significant Event)

mainbody.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 2, 2016 (April 27, 2016) HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdiction (Commis

April 29, 2016 EX-4

STOCK PURCHASE AGREEMENT

EXHIBIT 4 STOCK PURCHASE AGREEMENT This Stock Purchase Agreement (this "Agreement") is made as of April 20, 2016, by and among the sellers listed on Schedule 1 hereto (each a "Seller" and collectively, the "Sellers") and MVI Partners, LLC, an Ohio limited liability company (the "Purchaser").

April 29, 2016 SC 13D

HEWA / HealthWarehouse.com, Inc. / MVI PARTNERS, LLC - SCHEDULE 13-D Activist Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. ) HealthWarehouse.com, Inc. (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of Securities) 42227G202 (CUSIP Number) Joe Heimbrock MVI Partners, L

April 29, 2016 EX-1

JOINT FILING AGREEMENT

EXHIBIT 1 JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that the Schedule 13D to which this Joint Filing Agreement is being filed as an exhibit shall be a joint statement filed on behalf of each of the undersigned.

April 26, 2016 SC 13D/A

HEWA / HealthWarehouse.com, Inc. / Miller Lloyd I III - SC 13D/A Activist Investment

SC 13D/A 1 v437971sc13d-a.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 13) HealthWarehouse.com, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 42227G202 (CUSIP Number) Lloyd I. Miller, III 3300 South Dixie Highway Suite 1-365 West Palm Beach, Florida 33405 (561) 287-53

April 21, 2016 EX-10.1

Assignment and Assumption Agreement, dated April 20, 2016, by and among MVI Partners, LLC, certain of the holders of the Series B Preferred Stock and HealthWarehouse.com, Inc.

EXHIBIT 10.1 ASSIGNMENT AND ASSUMPTION AGREEMENT This Assignment and Assumption Agreement (the "Assignment and Assumption Agreement") is made and entered into as of April 20, 2016, by and among HWH Lending, LLC, MILFAM I, L.P., and David S. Oros and Marla T. Oros (each an "Assignor" and together the "Assignors"), and MVI Partners, LLC, an Ohio limited liability company ("Assignee"), and Healthware

April 21, 2016 8-K

HealthWarehouse.com MAINBODY (Current Report/Significant Event)

mainbody.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 21, 2016 (April 20, 2016) HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdiction (Com

April 6, 2016 EX-99.1

HealthWarehouse.com Reports 4th Quarter and 2015 Annual Results

Exhibit 99.1 HealthWarehouse.com Reports 4th Quarter and 2015 Annual Results Continued Sales & Gross Margin Expansion with Significant Reduction of Net Loss ( CINCINNATI, OH, March 31 , 2016) - HealthWarehouse.com, Inc. (OTCQB:HEWA), the only VIPPS accredited online pharmacy licensed in all 50 states, announced financial results for the year ended December 31, 2015. For the year ended December 31,

April 6, 2016 8-K

HealthWarehouse.com MAINBODY (Current Report/Significant Event)

mainbody.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 6, 2016 (March 31, 2016) HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdiction (Comm

March 25, 2016 10-K

HealthWarehouse.com MAINBODY (Annual Report)

mainbody.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2015 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from . Commission file number 0-13117 HEALTHWAREHOUSE.COM

March 25, 2016 EX-21.1

Subsidiaries of the Registrant.*

Exhibit 21.1 Subsidiaries of the Registrant Subsidiary Jurisdiction Ownership Hwareh.com, Inc. Delaware 100% owned by HealthWarehouse.com, Inc. Hocks.com, Inc. Ohio 100% owned by HealthWarehouse.com, Inc. Ion Networks Holding N.V. Belgium 799 shares are owned by HealthWarehouse.com, Inc. One share is owned by Stephen Gray, the Company’s former CEO. Ion Networks, N.V. Belgium 513 shares are owned b

March 25, 2016 EX-10.23

Fourth Amendment to Lease agreement dated as of March 15, 2016 between the Company and the landlord for 7017 Industrial Road Florence, Kentucky *

Exhibit 10.23 FOURTH AMENDMENT TO LEASE This FOURTH AMENDMENT TO LEASE ("FourthAmendment") is made and entered into as of March 15, 2016, by and between CIVF I-KY1M01-KY1M06 & KY1W01, LLC, a Delaware limited liability company ("Landlord"), and HEALTHWAREHOUSE.COM, INC., a Delaware corporation ("Tenant"). RECITALS WHEREAS, Landlord and Tenant entered into that certain Agreement of Lease dated June

February 25, 2016 SC 13G/A

HEWA / HealthWarehouse.com, Inc. / SCOTT MARK DOUGLAS - SC 13G/A Passive Investment

Cormag Holdings Ltd.: Schedule 13G/A - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240.13d -1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO §240.13d -2 (Amendment No. 1)1 HealthWarehouse.com, Inc. (Name of Issuer) Common Stock, $0.001 Par Value Per Share (Titl

February 12, 2016 SC 13G/A

HEWA / HealthWarehouse.com, Inc. / SINGER KAREN - SC 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A2 (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 2)* HealthWarehouse.com, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 42227G202 (CUSIP Number) December 31, 2015 (Date of Event which

January 25, 2016 EX-10.1

Amended and Restated Promissory Note dated January 19, 2006

EXHIBIT 10.1 AMENDED AND RESTATED PROMISSORY NOTE $1,000,000.00 January 19, 2016, to be effective as of December 31, 2015 (“Effective Date”) FOR VALUE RECEIVED, the undersigned, HEALTHWAREHOUSE.COM, INC., a Delaware corporation, HWAREH.COM, INC., a Delaware corporation, and HOCKS.COM, INC., an Ohio corporation, jointly and severally, (collectively, “Borrower”), with an address at 7107 Industrial R

January 25, 2016 8-K

HealthWarehouse.com MAINBODY (Current Report/Significant Event)

mainbody.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 25, 2016 (January 19, 2016) HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdiction

January 25, 2016 EX-99.2

HealthWarehouse.com Renews Senior Secured Debt With Melrose Capital Renewal Highlights Senior Lender’s Continued Confidence in Management & Business Model

EXHIBIT 99.1 HealthWarehouse.com Renews Senior Secured Debt With Melrose Capital Renewal Highlights Senior Lender’s Continued Confidence in Management & Business Model (CINCINNATI, OH, January 25, 2016) - HealthWarehouse.com, Inc. (OTCQB:HEWA), the only Verified Internet Pharmacy Practice Site (VIPPS) accredited online pharmacy licensed in all 50 states serving consumers who pay out of pocket for

January 14, 2016 EX-99.2

HealthWarehouse.com Appoints Daniel Seliga as Chief Operating Officer and Chief Financial Officer

EXHIBIT 99.2 HealthWarehouse.com Appoints Daniel Seliga as Chief Operating Officer and Chief Financial Officer (CINCINNATI, OH, January 14, 2016) – HealthWarehouse.com, Inc. (OTCQB:HEWA), the only VIPPS accredited online pharmacy licensed in all 50 states, announced today that it has appointed Daniel Seliga as Chief Operating Officer and Chief Financial Officer. “I am pleased to announce this new

January 14, 2016 EX-99.1

EMPLOYMENT AGREEMENT

exhibit991.htm EXHIBIT 99.1 EMPLOYMENT AGREEMENT EMPLOYMENT AGREEMENT, entered into as of January 11, 2016 (the ?Agreement?), by and between HealthWarehouse.com, Inc., a Delaware corporation (the ?Company?), and Dan Seliga (the ?Employee?). W I T N E S S E T H: WHEREAS, the Company desires to employ the Employee as its Chief Operating Officer and Chief Financial Officer so that it will have the be

January 14, 2016 8-K

HealthWarehouse.com MAINBODY (Current Report/Significant Event)

mainbody.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 14, 2016 (January 11, 2016) HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdiction

December 10, 2015 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 10, 2015 (December 9, 2015) HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdiction (Commission

November 17, 2015 EX-99.1

HealthWarehouse.com Reports 14.5% Quarterly Sales Growth Year over Year New Customers Grow 70.3% as Prescription Drug Orders Grow 17.3%

EX-99.1 2 exhibit991.htm EXHIBIT991 Exhibit 99.1 HealthWarehouse.com Reports 14.5% Quarterly Sales Growth Year over Year New Customers Grow 70.3% as Prescription Drug Orders Grow 17.3% (CINCINNATI, OH, November 17, 2015) -– HealthWarehouse.com, Inc. (OTCQB:HEWA), the only VIPPS accredited online and mail-order pharmacy licensed in all 50 states, announced financial results for the quarter ended Se

November 17, 2015 8-K

HealthWarehouse.com MAINBODY (Current Report/Significant Event)

mainbody.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 17, 2015 HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdiction (Commission File N

November 13, 2015 EX-10.2

Amended and Restated Promissory Note dated November 11, 2015 between the Company and Melrose Capital Advisors, LLC *

Exhibit 10.2 AMENDED AND RESTATED PROMISSORY NOTE $1,000,000.00 November 11, 2015, to be effective as of November 1, 2015 (?Effective Date?) FOR VALUE RECEIVED, the undersigned, HEALTHWAREHOUSE.COM, INC., a Delaware corporation, HWAREH.COM, INC., a Delaware corporation, and HOCKS.COM, INC., an Ohio corporation, jointly and severally, (collectively, ?Borrower?), with an address at 7107 Industrial R

November 13, 2015 EX-3.1

Warrant to Purchase 250,000 shares of the Common Stock of HealthWarehouse.com, Inc. dated November 11, 2015 and issued to Melrose Capital Advisors, Inc. *

Exhibit 3.1 WARRANT NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEME

November 13, 2015 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2015 ¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-13117 HealthWarehouse.com, In

November 13, 2015 EX-10.3

Deposit Account Control Agreement dated October 22, 2015 between the Company, Melrose Capital Advisors, LLC and Cheviot Savings Bank *

Exhibit 10.3 DEPOSIT ACCOUNT CONTROL AGREEMENT THIS DEPOSIT ACCOUNT CONTROL AGREEMENT (the “Agreement”) is made and entered into as of October 22, 2015, by and among CHEVIOT SAVINGS BANK (“Depository Bank”), HEALTHWAREHOUSE.COM, INC., a Delaware corporation, HWAREH.COM, INC., a Delaware corporation and HOCKS.COM, INC., an Ohio corporation, (collectively, “Borrower”), and MELROSE CAPITAL ADVISORS,

November 13, 2015 EX-10.1

Loan Extension Agreement dated November 11, 2015 between the Company and Melrose Capital Advisors, LLC *

Exhibit 10.1 LOAN EXTENSION AGREEMENT This Loan Extension Agreement (the “Agreement”) is entered into as of November 11, 2015 (the “Execution Date”), to be effective as of November 1, 2015 (the “Effective Date”), by and between HEALTHWAREHOUSE.COM, INC., a Delaware corporation, HWAREH.COM, INC., a Delaware corporation, and HOCKS.COM, INC., an Ohio corporation, jointly and severally, (collectively,

November 13, 2015 EX-3.2

Letter Agreement dated November 11, 2015 between the Company and Melrose Capital Advisors, LLC *

Exhibit 3.2 Letter Agreement between HealthWarehouse.com, Inc. and Melrose Capital, LLC Reference is made to the following documents: (i) Warrant to purchase 150,000 shares of common stock of HealthWarehouse.com, Inc. dated September 30, 2013 and issued to Melrose Capital Advisors, LLC; (ii) Warrant to purchase 150,000 shares of common stock of HealthWarehouse.com, Inc. dated March 28, 2014 and is

November 12, 2015 8-K

Current Report

mainbody.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 12, 2015 (November 11, 2015) HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdictio

October 19, 2015 8-K

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 16, 2015 HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdiction (Commission File Number) (IRS Em

September 22, 2015 8-K

Current Report

8-K 1 mainbody.htm MAINBODY UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 22, 2015 (September 16, 2015) HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or

September 18, 2015 DEF 14A

HealthWarehouse.com MAINBODY

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy State

September 10, 2015 8-K

Financial Statements and Exhibits

8-K 1 mainbody.htm MAINBODY UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 10, 2015 (September 8, 2015) HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or o

September 10, 2015 EX-10.1

Amendment to Amended and Restated Promissory Note

EXHIBIT 10.1 AMENDMENT TO AMENDED AND RESTATED PROMISSORY NOTE THIS AMENDMENT TO AMENDED AND RESTATED PROMISSORY NOTE (this "Amendment") is dated September 1, 2015, by and between HEALTHWAREHOUSE.COM, INC., a Delaware corporation, HWAREH.COM, INC., a Delaware corporation, and HOCKS.COM, INC., an Ohio corporation, jointly and severally, (collectively, “Borrower”), and MELROSE CAPITAL ADVISORS, LLC,

August 12, 2015 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

mainbody.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 12, 2015 (August 12, 2015) HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdiction (C

August 12, 2015 EX-99.1

HealthWarehouse.com Reports 27.9% Quarterly Sales Growth Year over Year Gross Margin Increases to 67% While Net Loss Narrows by 78.2%

exhibit991.htm EXHIBIT 99.1 HealthWarehouse.com Reports 27.9% Quarterly Sales Growth Year over Year Gross Margin Increases to 67% While Net Loss Narrows by 78.2% (CINCINNATI, OH, August 12, 2015) - HealthWarehouse.com, Inc. (OTCQB:HEWA), the only VIPPS accredited online and mail-order pharmacy licensed in all 50 states, today announced financial results for the quarter ended June 30, 2015. For the

August 10, 2015 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2015 ¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-13117 HealthWarehouse.com, Inc. (E

May 28, 2015 EX-99.2

Presentation used at the Marcum LLP MicroCap Conference on May 27, 2015

exhibit992.htm EXHIBIT 99.2

May 28, 2015 EX-99.1

HealthWarehouse.com to Present at the 2015 Marcum MicroCap Conference

EX-99.1 2 exhibit991.htm EXHIBIT991 EXHIBIT 99.1 HealthWarehouse.com to Present at the 2015 Marcum MicroCap Conference (CINCINNATI, OH, May 26, 2015) - HealthWarehouse.com, Inc. (OTCQB:HEWA), the only VIPPS accredited online and mail-order pharmacy licensed in all 50 states, announced today that it will present at the 2015 Marcum MicroCap Conference on Wednesday, May 27, 2015 in New York City at t

May 28, 2015 8-K

Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 28, 2015 (May 26, 2015) HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdiction (Commission File Numb

May 14, 2015 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 14, 2015 (May 14, 2015) HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdiction (Commission File Numb

May 14, 2015 EX-99.1

HealthWarehouse.com Reports 9.3% Sales Growth Quarter over Quarter Net Loss Narrows by 65.6% While Gross Margin Remains Steady at 61%

exhibit991.htm EXHIBIT 99.1 HealthWarehouse.com Reports 9.3% Sales Growth Quarter over Quarter Net Loss Narrows by 65.6% While Gross Margin Remains Steady at 61% (CINCINNATI, OH, May 14, 2015) - HealthWarehouse.com, Inc. (OTCQB:HEWA), the only VIPPS accredited online and mail-order pharmacy licensed in all 50 states, today announced financial results for the quarter ended March 31, 2015. For the q

May 11, 2015 EX-10.1

Third Amendment to Lease dated as of April 27, 2015

EXHIBIT 10.1 THIRD AMENDMENT TO LEASE This THIRD AMENDMENT TO LEASE (?Third Amendment?) is made and entered into as of April 27, 2015, by and between CIVF I-KY1M01-KY1M06 & KY1W01, LLC, a Delaware limited liability company (?Landlord?), and HEALTHWAREHOUSE.COM, INC., a Delaware corporation (?Tenant?). RECITALS WHEREAS, Landlord and Tenant entered into that certain Agreement of Lease dated June 15,

May 11, 2015 EX-4.1

Warrant to Purchase 137,430 shares of the Common Stock of Healthwarehouse.com, Inc. dated April 3, 2015 and issued to Brian Corona.

EXHIBIT 4.1 FORM OF WARRANT NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION

May 11, 2015 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2015 ¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-13117 HealthWarehouse.com, Inc. (

May 6, 2015 RW

HealthWarehouse.com MAINBODY

RW 1 mainbody.htm MAINBODY May 6, 2015 VIA EDGAR Division of Corporation Finance Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Re: HealthWarehouse.com, Inc. Withdrawal of Registration Statement on Form S-B filed on April 27, 2015 Commission File No. 333-203680 Ladies and Gentlemen: Pursuant to Rule 477 of the Securities Act of 1933, please withdraw the above referenced

April 28, 2015 EX-5.0

Opinion of Silver, Freedman, Taff & Tiernan LLP as to legality of the Common Stock

exhibit50.htm EXHIBIT 5.0 LAW OFFICES SILVER, FREEDMAN, TAFF & TIERNAN LLP SUITE 100 3299 K STREET, N.W. WASHINGTON, D.C. 20007 ????? TELEPHONE: (202) 295-4500 FACSIMILE: (202) 337-5502 WWW.SFTTLAW.COM April 27, 2015 Board of Directors HealthWarehouse.com, Inc. 7107 Industrial Road Florence, Kentucky 41042 Re: Registration Statement on Form S-8 2014 Stock Equity Plan 6,000,000 Shares of Common Sto

April 28, 2015 S-8

HealthWarehouse.com MAINBODY

mainbody.htm Registration No. 333- Filed April 27, 2015 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 22-2413505 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.) 7107 I

April 27, 2015 S-B

HealthWarehouse.com MAINBODY

mainbody.htm Registration No. 333- Filed April 27, 2015 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 22-2413505 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.) 7107 I

April 27, 2015 EX-5.0

Opinion of Silver, Freedman, Taff & Tiernan LLP as to legality of the Common Stock

exhibit50.htm EXHIBIT 5.0 LAW OFFICES SILVER, FREEDMAN, TAFF & TIERNAN LLP SUITE 100 3299 K STREET, N.W. WASHINGTON, D.C. 20007 ????? TELEPHONE: (202) 295-4500 FACSIMILE: (202) 337-5502 WWW.SFTTLAW.COM April 27, 2015 Board of Directors HealthWarehouse.com, Inc. 7107 Industrial Road Florence, Kentucky 41042 Re: Registration Statement on Form S-8 2014 Stock Equity Plan 6,000,000 Shares of Common Sto

April 3, 2015 8-K

HealthWarehouse.com MAINBODY (Current Report/Significant Event)

mainbody.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 3, 2015 (April 2, 2015) HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdiction (Commi

April 3, 2015 EX-99.1

HealthWarehouse.com Reports 2014 Annual Results (CINCINNATI, OH, April 2, 2015) -- HealthWarehouse.com, Inc. (OTCQB:HEWA), the only VIPPS accredited online and mail-order pharmacy licensed in all 50 states, today announced financial results for the y

exhibit991.htm EXHIBIT 99.1 HealthWarehouse.com Reports 2014 Annual Results (CINCINNATI, OH, April 2, 2015) - HealthWarehouse.com, Inc. (OTCQB:HEWA), the only VIPPS accredited online and mail-order pharmacy licensed in all 50 states, today announced financial results for the year ended December 31, 2014. For the year ended December 31, 2014, gross margin improved to 59.3%, up from 50.0%, while net

March 30, 2015 EX-10.24

Deposit Account Control Agreement dated August 18, 2014 between the Company, Melrose Capital Advisors, LLC and The Bank of Kentucky, Inc.

Exhibit 10.24 DEPOSIT ACCOUNT CONTROL AGREEMENT THIS DEPOSIT ACCOUNT CONTROL AGREEMENT (the “Agreement”) is made and entered into as of August 18, 2014, by and among THE BANK OF KENTUCKY, INC., a Kentucky banking corporation (“Depository Bank”), HEALTHWAREHOUSE.COM, INC., a Delaware corporation, HWAREH.COM, INC., a Delaware corporation and HOCKS.COM, INC., an Ohio corporation, PAGOSA HEALTH LLC, a

March 30, 2015 EX-10.28

Warrant to Purchase 500,000 shares of the Common Stock of HealthWarehouse.com, Inc. dated March 1, 2015 and issued to Melrose Capital Advisors, LLC.

Exhibit 10.28 FORM OF WARRANT NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATI

March 30, 2015 EX-10.29

Waiver Letter dated March 15, 2015 from Melrose Capital Advisors, LLC.

Exhibit 10.29 MELROSE CAPITAL ADVISORS, LLC March 10, 2015 Via email: [email protected] Lalit Dhadphale President and CEO HEALTHWAREHOUSE.COM, INC. 7107 Industrial Road Florence, Kentucky 41042 Re: Default under $750,000 Amended and Restated Promissory Note dated April 29, 2014, as amended, made by HEALTHWAREHOUSE.COM, Inc. and its affiliates payable to Melrose Capital Advisors, LLC Dear L

March 30, 2015 EX-10.27

Amended and Restated Promissory Note dated March 1, 2015 between the Company and Melrose Capital Advisors, LLC.

Exhibit 10.27 AMENDED AND RESTATED PROMISSORY NOTE $750,000.00 March 1, 2015 (?Effective Date?) FOR VALUE RECEIVED, the undersigned, HEALTHWAREHOUSE.COM, INC., a Delaware corporation, HWAREH.COM, INC., a Delaware corporation, and HOCKS.COM, INC., an Ohio corporation, jointly and severally, (collectively, ?Borrower?), with an address at 7107 Industrial Road, Florence, Kentucky 41042, hereby promise

March 30, 2015 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2014 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from . Commission file number 0-13117 HEALTHWAREHOUSE.COM, INC. (Exact

March 30, 2015 EX-3.1

CERTIFICATION OF C.E.O. PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

EX-3.1 7 exhibit311.htm EXHIBIT311 Exhibit 31.1 CERTIFICATION OF C.E.O. PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 The undersigned, in the capacity and date indicated below, hereby certifies that: 1. I have reviewed this annual report on Form 10-K of HealthWarehouse.com, Inc. 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to st

March 30, 2015 EX-21.1

Subsidiaries of the Registrant

Exhibit 21.1 Subsidiaries of the Registrant Subsidiary Jurisdiction Ownership Hwareh.com, Inc. Delaware 100% owned by HealthWarehouse.com, Inc. Hocks.com, Inc. Ohio 100% owned by HealthWarehouse.com, Inc. Ion Networks Holding N.V. Belgium 799 shares are owned by HealthWarehouse.com, Inc. One share is owned by Stephen Gray, the Company?s former CEO. Ion Networks, N.V. Belgium 513 shares are owned b

March 11, 2015 8-K

HealthWarehouse.com MAINBODY (Current Report/Significant Event)

mainbody.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 11, 2015 (March 9, 2015) HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdiction (Comm

February 9, 2015 SC 13G/A

HEWA / HealthWarehouse.com, Inc. / SINGER KAREN - SC 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A1 (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 1)* HealthWarehouse.com, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 42227G202 (CUSIP Number) December 31, 2014 (Date of Event which

February 5, 2015 SC 13D/A

HEWA / HealthWarehouse.com, Inc. / NEW ATLANTIC VENTURE FUND III L P - SC 13D/A Activist Investment

SC 13D/A Securities and Exchange Commission Washington, DC 20549 SCHEDULE 13D/A (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.

January 29, 2015 SC 13G/A

HEWA / HealthWarehouse.com, Inc. / SCOTT MARK DOUGLAS - SCHEDULE 13G/A Passive Investment

SC 13G/A 1 sched13ga.htm SCHEDULE 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO §240.13d-2 (Amendment No. 1)1 HealthWarehouse.com, Inc. (Name of Issuer) Common Stock, $0.001 Par Value Per Share (Title of Class of Securities) 4

January 29, 2015 SC 13G/A

HEWA / HealthWarehouse.com, Inc. / Cormag Holdings, Ltd. - SCHEDULE 13G/A Passive Investment

SC 13G/A 1 sched13ga.htm SCHEDULE 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO §240.13d-2 (Amendment No. 1)1 HealthWarehouse.com, Inc. (Name of Issuer) Common Stock, $0.001 Par Value Per Share (Title of Class of Securities) 4

December 19, 2014 SC 13G

HEWA / HealthWarehouse.com, Inc. / Osgar Holdings Ltd. - SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO §240.13d-2 (Amendment No. )1 HealthWarehouse.com, Inc. (Name of Issuer) Common Stock, $0.001 Par Value Per Share (Title of Class of Securities) 42227G202 (CUSIP Number) October 23, 2014 (D

November 14, 2014 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2014 ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-13117 HealthWarehouse.com, In

November 14, 2014 EX-10.1

State of Delaware Certificate of Amendment of Certificate of Incorporation dated October 17, 2014 *

Exhibit 10.1 Page 1 of 2 Page 2 of 2

November 3, 2014 SC 13D/A

HEWA / HealthWarehouse.com, Inc. / Miller Lloyd I III - SC 13D/A Activist Investment

SC 13D/A 1 v392983sc13d-a.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 12) HealthWarehouse.com, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 42227G202 (CUSIP Number) Lloyd I. Miller, III 3300 South Dixie Highway Suite 1-365 West Palm Beach, Florida 33405 (561) 287-53

October 29, 2014 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 29, 2014 (October 23, 2013) HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdiction (Commission F

October 22, 2014 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 17, 2014 HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdiction (Commission File Number) (IRS Em

October 21, 2014 8-K

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 17, 2014 HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdiction (Commission File Number) (IRS Em

September 26, 2014 SC 13G

HEWA / HealthWarehouse.com, Inc. / Cormag Holdings, Ltd. - SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO §240.13d-2 (Amendment No. )1 HealthWarehouse.com, Inc. (Name of Issuer) Common Stock, $0.001 Par Value Per Share (Title of Class of Securities) 42227G202 (CUSIP Number) August 21, 2014 (Da

September 26, 2014 SC 13G

HEWA / HealthWarehouse.com, Inc. / SCOTT MARK DOUGLAS - SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO §240.13d-2 (Amendment No. )1 HealthWarehouse.com, Inc. (Name of Issuer) Common Stock, $0.001 Par Value Per Share (Title of Class of Securities) 42227G202 (CUSIP Number) August 21, 2014 (Da

September 26, 2014 DEF 14A

HEWA / HealthWarehouse.com, Inc. DEF 14A - - MAINBODY.HTM

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy State

September 18, 2014 SC 13G

HEWA / HealthWarehouse.com, Inc. / Bedrick Bruce - SC 13G Passive Investment

SC 13G 1 sc13g-bedrick091814.htm SC 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 HealthWarehouse.com, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 42227G202 (CUSIP Number) August 20, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whi

September 10, 2014 CORRESP

HEWA / HealthWarehouse.com, Inc. CORRESP - -

Law Offices Silver, Freedman, Taff & Tiernan LLP A Limited Liability Partnership Including Professional Corporations 3299 K STREET, N.

September 10, 2014 PRER14A

HEWA / HealthWarehouse.com, Inc. PRER14A - - MAINBODY.HTM

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: x Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy State

August 29, 2014 PRE 14A

HEWA / HealthWarehouse.com, Inc. PRE 14A - - MAINBODY.HTM

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: x Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy State

August 26, 2014 EX-4.1

FORM OF WARRANT

EXHIBIT 4.1 FORM OF WARRANT NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION

August 26, 2014 8-K

Current Report

8-K 1 form8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 26, 2014 (August 21, 2014) HealthWarehouse.com, Inc. (Exact name of registrant as specified in its charter) Delaware 0-13117 22-2413505 (State or other

August 26, 2014 EX-10.1

SECURITIES PURCHASE AGREEMENT OF HEALTHWAREHOUSE.COM, INC.

EXHIBIT 10.1 SECURITIES PURCHASE AGREEMENT OF HEALTHWAREHOUSE.COM, INC. BETWEEN: (the “Purchaser”) AND: HEALTHWAREHOUSE.COM, INC., of 7107 Industrial Road, Florence, KY 41042 (the “Issuer”) The Issuer is offering up to $1.75 million of common stock in a private offering to accredited investors. Subject and pursuant to the terms set out in “Terms and Conditions”, attached to this Securities Purchas

August 19, 2014 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2014 ¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-13117 HealthWarehouse.com, Inc. (E

August 14, 2014 NT 10-Q

HEWA / HealthWarehouse.com, Inc. NT 10-Q - - MAINBODY

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: June 30, 2014 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q o Transition Report on Fo

May 30, 2014 8-K

Regulation FD Disclosure, Financial Statements and Exhibits - MAINBODY

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 30, 2014 (May 29, 2014) HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdiction (Commission File Numb

May 30, 2014 EX-99.1

Page 1 of 27

Page 1 of 27 Page 2 of 27 Page 3 of 27 Page 4 of 27 Page 5 of 27 Page 6 of 27 Page 7 of 27 Page 8 of 27 Page 9 of 27 Page 10 of 27 Page 11 of 27 Page 12 of 27 Page 13 of 27 Page 14 of 27 Page 15 of 27 Page 16 of 27 Page 17 of 27 Page 18 of 27 Page 19 of 27 Page 20 of 27 Page 21 of 27 Page 22 of 27 Page 23 of 27 Page 24 of 27 Page 25 of 27 Page 26 of 27 Page 27 of 27

May 23, 2014 EX-99.1

HealthWarehouse.com Reports First Quarter 2014 Results Corporate Refocusing Leads to Second Consecutive Quarter of Positive EBITDAS

Exhibit 99.1 HealthWarehouse.com Reports First Quarter 2014 Results Corporate Refocusing Leads to Second Consecutive Quarter of Positive EBITDAS (CINCINNATI, OH, May 22, 2014) - HealthWarehouse.com, Inc. (OTCQB:HEWA), the only VIPPS accredited online and mail-order pharmacy licensed in all 50 states, today announced financial results for the first quarter ended March 31, 2014. For the three months

May 23, 2014 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition - MAINBODY

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 23, 2014 (May 22, 2014) HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other jurisdiction (Commission File Numb

May 16, 2014 EX-4.1

Amended and Restated Promissory Note dated April 29, 2014 in the amount of $750,000 payable by the Company to the order of Melrose Capital Advisors, LLC *

EXHIBIT 4.1 AMENDED AND RESTATED PROMISSORY NOTE $750,000.00 April 29, 2014 (?Effective Date?) FOR VALUE RECEIVED, the undersigned, HEALTHWAREHOUSE.COM, INC., a Delaware corporation, HWAREH.COM, INC., a Delaware corporation, HOCKS.COM, INC., an Ohio corporation, and PAGOSA HEALTH LLC, an Indiana corporation, jointly and severally, (collectively, ?Borrower?), with an address at 7107 Industrial Road

May 16, 2014 10-Q

UNITED STATES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2014 ¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-13117 HealthWarehouse.com, Inc. (

May 16, 2014 EX-4.2

Common Stock Purchase Warrant dated April 29, 2014 for 75,000 common shares *

EXHIBIT 4.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR T

May 16, 2014 NT 10-Q

- MAINBODY

NT 10-Q 1 mainbody.htm MAINBODY UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: March 31, 2014 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Fo

April 23, 2014 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 form8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 23, 2014 (April 21, 2014) HealthWarehouse.com, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-13117 22-2413505 (State or other juri

April 23, 2014 EX-99.1

HealthWarehouse.com Reports 2013 Year-End and Q4 Results Company Achieves Positive EBITDAS for Q4’2013

EX-99.1 2 pr.htm PRESS RELEASE HealthWarehouse.com Reports 2013 Year-End and Q4 Results Company Achieves Positive EBITDAS for Q4’2013 (CINCINNATI, OH, April 21, 2014) - HealthWarehouse.com, Inc. (OTCQB:HEWA), the only VIPPS accredited online and mail-order pharmacy licensed in all 50 states, today announced financial results for the year-end and fourth quarter ended December 31, 2013. For the year

April 15, 2014 EX-10.16

Warrant to Purchase 150,000 shares of the Common Stock of HealthWarehouse.com, Inc. dated September 30, 2013 and issued to Melrose Capital Advisors, LLC.

Exhbit 10.16 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR

April 15, 2014 EX-10.20

Subordination Agreement dated October 30, 2013 among Melrose Capital Advisors, LLC, the Company and Steven Deixler

Exhibit 10.20 SUBORDINATION AGREEMENT THIS SUBORDINATION AGREEMENT (this “Agreement”) is entered into as of the 30th day of October, 2013, by and among MELROSE CAPITAL ADVISORS, LLC, an Ohio limited liability company (the “Lender”), HEALTHWAREHOUSE.COM, INC., a Delaware corporation, HWAREH.COM, INC., a Delaware corporation, and HOCKS.COM, INC., an Ohio corporation (collectively, the “Borrower”), a

April 15, 2014 EX-10.21

Amended and Restated Promissory Note dated March 28, 2014 in the amount of $700,000 payable by the Company to the order of Melrose Capital Advisors, LLC

Exhibit 10.21 AMENDED AND RESTATED PROMISSORY NOTE $700,000.00 March 28, 2014 (?Effective Date?) FOR VALUE RECEIVED, the undersigned, HEALTHWAREHOUSE.COM, INC., a Delaware corporation, HWAREH.COM, INC., a Delaware corporation, HOCKS.COM, INC., an Ohio corporation, and PAGOSA HEALTH LLC, an Indiana corporation, jointly and severally, (collectively, ?Borrower?), with an address at 7107 Industrial Ro

April 15, 2014 EX-10.15

Amended and Restated Promissory Note dated September 30, 2013 in the amount of $600,000 payable by the Company to the order of Melrose Capital Advisors, LLC

Exhibit 10.15 AMENDED AND RESTATED PROMISSORY NOTE $600,000.00 September 30, 2013 (“Effective Date”) FOR VALUE RECEIVED, the undersigned, HEALTHWAREHOUSE.COM, INC., a Delaware corporation, HWAREH.COM, INC., a Delaware corporation, HOCKS.COM, INC., an Ohio corporation, and PAGOSA HEALTH LLC, an Indiana corporation, jointly and severally, (collectively, “Borrower”), with an address at 7107 Industria

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista